Genesee Capital Advisors’s Clorox CLX Stock Holding History

Genesee Capital Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,381	Closed	-$856K	–	94
2023 Q2	$856K	Buy	+5,381	New	+$868K	0.58%	46

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Genesee Capital Advisors's CLX Position: Q3 2023 in Review

Genesee Capital Advisors sold out of Clorox (CLX) in Q3 2023, closing a stake of 5,381 shares — an estimated $856K sold.

Genesee Capital Advisors first reported a position in CLX in Q2 2023 and held it in 1 quarter. The position peaked at $856K in Q2 2023. 1,065 funds tracked by Wall St. Rank hold CLX as of Q3 2023.

Genesee Capital Advisors reported no remaining Clorox position as of Q3 2023 after selling out during the quarter.
Genesee Capital Advisors sold 5,381 Clorox shares in Q3 2023, an estimated $856K.
Genesee Capital Advisors first reported a position in Clorox in Q2 2023 and held it in 1 quarter.
Genesee Capital Advisors's Clorox position peaked at $856K in Q2 2023.
1,065 funds tracked by Wall St. Rank held Clorox as of Q3 2023.

Based on Genesee Capital Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.